Farmington Hills is a city in Oakland County in the U.S. state of Michigan. Its population was 83,986 at the 2020 census. It is a northern suburb of Metro Detroit and is the second most-populated city in Oakland County after Troy.

During the past decade, Farmington Hills, Michigan conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Farmington Hills, Michigan" are "Parkinson Disease" (3 trials). Many other conditions were trialed in "Farmington Hills, Michigan" in a lesser frequency.

Most popular intervention types in "Farmington Hills, Michigan" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tavapadon" (2 trials), "Ropinirole Implant" (1 trials) and "Ropinirole oral product" (1 trials). Other intervention names were less common.

The vast majority of trials in "Farmington Hills, Michigan" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Farmington Hills, Michigan". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Farmington Hills, Michigan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Farmington Hills, Michigan, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".